{
    "2018-09-30": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Here's What Could Cause Neurocrine Biosciences Shares to Skyrocket",
                "features": {
                    "keywords": [
                        "Neurocrine Biosciences",
                        "Skyrocket",
                        "Cause"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Better Buy: AbbVie Inc. vs. Eli Lilly and Company",
                "features": {
                    "keywords": [
                        "AbbVie Inc.",
                        "Eli Lilly",
                        "Better Buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}